

We Go Together: Johnson & Johnson on talent clusters, biotech innovation and venture capital flows in Life Sciences
Aug 21, 2023
Melinda Richter, Johnson & Johnson's Global Head of Innovation - JLABS, discusses finding, funding and incubating startups with expert commentary from CBRE on challenges faced by the life sciences industry, recovery in the pharmaceutical market, J Labs providing non-deluded financing, drug design trends, and opportunities in the life sciences industry.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 4min
The Market Rush and Recovery in the Pharmaceutical Industry
03:34 • 2min
J Labs: Non-Deluded Financing for Life Science Companies
05:10 • 22min
Drug design trends, cost of drug development, and balancing safety with earlier approvals
27:22 • 5min
Tapping into the Life Sciences Industry: Adapting Office Buildings and Exploring Opportunities
32:44 • 6min